Literature DB >> 6951584

Comparison of diflunisal and paracetamol in the management of pain following wisdom teeth removal.

G H Irvine, M J Lutterloch, J E Bowerman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6951584     DOI: 10.1038/sj.bdj.4804728

Source DB:  PubMed          Journal:  Br Dent J        ISSN: 0007-0610            Impact factor:   1.626


× No keyword cloud information.
  6 in total

Review 1.  Single dose oral diflunisal for acute postoperative pain in adults.

Authors:  Jack O Wasey; Sheena Derry; R Andrew Moore; Henry J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

2.  Prospective, randomized, open-label, pilot clinical trial comparing the effects of dexamethasone coadministered with diclofenac potassium or acetaminophen and diclofenac potassium monotherapy after third-molar extraction in adults.

Authors:  Babatunde Olamide Bamgbose; Jelili Adisa Akinwande; Wasiu Lanre Adeyemo; Akinola Ladipo Ladeinde; Godwin Toyin Arotiba; Mobolanle Olugbemiga Ogunlewe
Journal:  Curr Ther Res Clin Exp       Date:  2006-07

3.  [The role of non-opioid analgesics in the management of postoperative pain.].

Authors:  I M Bowdler; W Seeling
Journal:  Schmerz       Date:  1993-06       Impact factor: 1.107

4.  Comparison between lidocaine and bupivacaine as local anesthetics with diflunisal for postoperative pain control after lower third molar surgery.

Authors:  J B Rosenquist; K I Rosenquist; P K Lee
Journal:  Anesth Prog       Date:  1988 Jan-Feb

Review 5.  Single dose oral paracetamol (acetaminophen) for postoperative pain in adults.

Authors:  Laurence Toms; Henry J McQuay; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

6.  Effectiveness of green tea mouthwash in postoperative pain control following surgical removal of impacted third molars: double blind randomized clinical trial.

Authors:  Majid Eshghpour; Hamed Mortazavi; Naser Mohammadzadeh Rezaei; AmirHossein Nejat
Journal:  Daru       Date:  2013-07-18       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.